PAVmed (PAVM) Non Operating Investment Income (2024 - 2026)

PAVmed has reported Non Operating Investment Income for 3 years, with the latest figure at -$2.5 million in Q2 2026.

• On a quarterly basis, Non Operating Investment Income rose 76.47% year-over-year to -$2.5 million in Q2 2026; TTM through Jun 2026 was -$15.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $8.5 million, up 1494.55% from the prior year.
• Non Operating Investment Income was -$2.5 million for Q2 2026 at PAVmed, down from $2.5 million in the prior quarter.
• The five-year high for Non Operating Investment Income was $21.0 million in Q1 2025, with the low at -$10.6 million in Q2 2025.
• Average Non Operating Investment Income over 3 years is $1.0 million, with a median of -$1.2 million recorded in 2024.
• The sharpest annual moves came in 2025 and 2026: Non Operating Investment Income jumped 1903.2% in 2025, then surged 76.47% in 2026.
• Over 3 years, Non Operating Investment Income stood at $125000.0 in 2024, then surged by 1903.2% to $2.5 million in 2025, then slumped by 200.0% to -$2.5 million in 2026.
• The last three Non Operating Investment Income figures came in at -$2.5 million (Q2 2026), $2.5 million (Q4 2025), and -$4.4 million (Q3 2025), per Business Quant data.